NCT06267300 - Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

April 1, 2026

Conditions

Post-COVID-19 SyndromePost-COVID SyndromePost COVID-19 ConditionPost-COVID ConditionPost COVID-19 Condition, UnspecifiedLong COVIDLong Covid19

Interventions

DRUG

Hyperbaric oxygen

Hyperbaric oxygen therapy (2.4 ATA, 40 sessions)

Trial Locations (7)

Da Vinci Clinic, Amersfoort

Da Vinci Clinic, Geldrop

Da Vinci Clinic, Hoogeveen

HGC Rijswijk, Rijswijk

Da Vinci Clinic, Rotterdam

Erasmus MC, Rotterdam

Da Vinci Clinic, Waalwijk